P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients

被引:0
|
作者
Ruoping Tang
Simy Cohen
Jean-Yves Perrot
Anne-Marie Faussat
Claudia Zuany-Amorim
Zora Marjanovic
Hamid Morjani
Fanny Fava
Elise Corre
Ollivier Legrand
Jean-Pierre Marie
机构
[1] Assistance Publique – Hôpitaux de Paris,
[2] Hôpital Hôtel Dieu,undefined
[3] Université Pierre et Marie Curie,undefined
[4] UMRs 872,undefined
[5] Equipe 18,undefined
[6] INSERM,undefined
[7] SANOFI-AVENTIS,undefined
[8] JE Onco-Pharmacologie,undefined
[9] IFR53; UFR de Pharmacie,undefined
来源
BMC Cancer | / 9卷
关键词
Acute Myeloid Leukaemia; Vinca Alkaloid; Gemtuzumab Ozogamicin; Acute Myeloid Leukaemia Patient; Acute Myeloid Leukaemia Cell;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 1 条
  • [1] P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients
    Tang, Ruoping
    Cohen, Simy
    Perrot, Jean-Yves
    Faussat, Anne-Marie
    Zuany-Amorim, Claudia
    Marjanovic, Zora
    Morjani, Hamid
    Fava, Fanny
    Corre, Elise
    Legrand, Ollivier
    Marie, Jean-Pierre
    BMC CANCER, 2009, 9